Changes in pulse pressure correlated with fluid-induced changes in cardiac output (r=0.56, p<0.0001), but were unable to reliably detect changes in cardiac output induced by norepinephrine.
Observational (n=373)
Does systemic arterial pulse pressure accurately reflect changes in cardiac output induced by fluid challenge or norepinephrine in patients with acute circulatory failure?
Pulse pressure can be used as a surrogate to detect fluid-induced changes in cardiac output, but it is unreliable for monitoring changes induced by norepinephrine.
Effect estimate: r = 0.56
p-value: p=<0.0001
OBJECTIVE: To evaluate to which extent the systemic arterial pulse pressure could be used as a surrogate of cardiac output for assessing the effects of a fluid challenge and of norepinephrine. DESIGN: Observational study. SETTING: Medical intensive care unit. PATIENTS: Patients with an acute circulatory failure who received a fluid challenge (228 patients, group 1) or in whom norepinephrine was introduced or increased (145 patients, group 2). INTERVENTIONS: We measured the systolic, diastolic, and mean arterial pressure, pulse pressure, and the transpulmonary thermodilution cardiac output before and after the therapeutic interventions. MAIN RESULTS: In group 1, the fluid challenge significantly increased cardiac output by 24% ± 25%. It significantly increased cardiac output by ≥15% (+35% ± 27%) in 142 patients ("responders"). The fluid-induced changes in cardiac output were correlated with the changes in pulse pressure (r = .56, p < .0001), systolic arterial pressure (r = .55, p < .0001), diastolic arterial pressure (r = .37, p < .0001), and mean arterial pressure (r = .52, p < .0001). At multivariate analysis, changes in pulse pressure were significantly related to changes in stroke volume (multiple r = .52) and to age (r = .12). A fluid-induced increase in pulse pressure of ≥17% allowed detecting a fluid-induced increase in cardiac output of ≥15% with a sensitivity of 6556-72% and a specificity of 8576-92%. The area under the receiver operating characteristic curves for the fluid-induced changes in mean arterial pressure and in diastolic arterial pressure was significantly lower than for pulse pressure. In group 2, the introduction/increase of norepinephrine significantly increased cardiac output by 14% ± 18%. The changes in cardiac output induced by the introduction/increase in the dose of norepinephrine were correlated with the changes in pulse pressure and systolic arterial pressure (r = .21 and .29, respectively, p = .001) but to a significantly lesser extent than in group 1. CONCLUSIONS: Pulse pressure and systolic arterial pressure could be used for detecting the fluid-induced changes in cardiac output, in spite of a significant proportion of false-negative cases. By contrast, the changes in pulse pressure and systolic arterial pressure were unable to detect the changes in cardiac output induced by norepinephrine.
Monnet et al. (Fri,) conducted a observational in Acute circulatory failure (n=373). Fluid challenge or norepinephrine was evaluated on Correlation between changes in cardiac output and changes in pulse pressure (r = 0.56, p=<0.0001). Changes in pulse pressure correlated with fluid-induced changes in cardiac output (r=0.56, p<0.0001), but were unable to reliably detect changes in cardiac output induced by norepinephrine.